Loss of SMARCA2 is an Adverse Prognostic Finding for Patients with Hepatocellular Carcinoma and Correlates with Early Disease Recurrence After Hepatectomy
LABORATORY INVESTIGATION(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
LABORATORY INVESTIGATION(2022)